ALB and diabetic kidney disease: Treating with TUDCA, a small molecular chemical chaperon, which effectively inhibited ER stress, could lower the blood glucose level, alleviate tubulointerstitial fibrosis, improve diabetic nephropathy–associated parameters, including the urine albumin and creatinine ratio and urine albumin excretion, and reduce apoptotic tubular cells in diabetic db/db mice.